Request a copy of the file

Enter the following information to request a copy for the following item: First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma.

Requesting the following file: 1696.full.pdf

This email address is used for sending the file.
Files
Back